SCHEMBL26339999

SCHEMBL26339999

c1ccc(-c2c(-c3ccccc3)c3cc(-c4ccc(N(c5ccc6ccccc6c5)c5ccc6c(ccc7ccccc76)c5)cc4)ccc3c3ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.39
ESR2 Q92731 6/20 0.39
HPRT1 P00492 3/20 0.37
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
HSD17B1 P14061 2/20 0.35
HSD17B2 P37059 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2B6 P20813 1/20 0.35
ALDH1A1 P00352 2/20 0.35
HIF1A Q16665 2/20 0.35
CYP1B1 Q16678 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PTGES O14684 1/20 0.34
ALOX5 P09917 1/20 0.34
SOS1 Q07889 1/20 0.34
GPR84 Q9NQS5 2/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26339959 0.99 ESR1 (0.41) ESR1ESR2HPRT1CYP1A2CYP2D6
SCHEMBL26339953 0.99 ESR1 (0.41) ESR1ESR2HPRT1CYP1A2CYP2D6
SCHEMBL26340038 0.99 ESR1 (0.41) ESR1ESR2HPRT1CYP1A2CYP2D6
SCHEMBL26339955 0.97 ESR1 (0.42) ESR1ESR2HPRT1CYP1A2CYP2D6
SCHEMBL26339884 0.97 ESR1 (0.42) ESR1ESR2HPRT1CYP1A2CYP2D6
SCHEMBL26340043 0.97 ESR1 (0.40) ESR1ESR2HPRT1CYP1A2CYP2D6
SCHEMBL26335949 0.96 ESR1 (0.41) ESR1ESR2HPRT1CYP1A2CYP2D6
SCHEMBL26335887 0.96 ESR1 (0.41) ESR1ESR2HPRT1CYP1A2CYP2D6
SCHEMBL26339951 0.96 ESR1 (0.43) ESR1ESR2HPRT1CYP1A2CYP2D6
SCHEMBL26340002 0.96 ESR1 (0.38) ESR1ESR2HPRT1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 US disclosed
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, ELAVL1, PIEZO1 ESR1 74/4885ESR2 419/4885HPRT1 1545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.